Gri bio announces notice of allowance for canadian patent covering proprietary natural killer t (nkt) cell modulators

Company advancing an innovative pipeline of nkt cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases

GRI Ratings Summary

GRI Quant Ranking